Close Menu

In Cell Metabolism this week, Francis Collins and his colleagues at the National Human Genome Research Institute provide a "global snapshot of the human islet epigenome," with which they've elucidated insights into type 2 diabetes susceptibility loci. By performing a genome-wide analysis of sites hypersensitive to DNAse I, the NHGRI-led team found around 18,000 putative promoters, several hundred of which were previously "unannotated and islet-active," the authors write.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.